Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 12/20 | 0.55 |
| ▸ | MEN1 | O00255 | 10/20 | 0.55 |
| ▸ | CRHBP | P24387 | 1/20 | 0.49 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 4/20 | 0.48 |
| ▸ | DHFR | P00374 | 2/20 | 0.48 |
| ▸ | MAPT | P10636 | 3/20 | 0.48 |
| ▸ | USP2 | O75604 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | TNFRSF1A | P19438 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22923969 | 0.97 | KMT2A (0.52) | KMT2AMEN1CRHBPCRHR2POLB | |
| SCHEMBL24251250 | 0.97 | KMT2A (0.52) | KMT2AMEN1CRHBPCRHR2POLB | |
| SCHEMBL24614126 | 0.90 | KMT2A (0.60) | KMT2AMEN1CRHBPCRHR2POLB | |
| SCHEMBL26277404 | 0.87 | KMT2A (0.52) | KMT2AMEN1CRHBPCRHR2POLB | |
| SCHEMBL24614128 | 0.87 | KMT2A (0.71) | KMT2AMEN1CRHBPCRHR2POLB | |
| SCHEMBL22923973 | 0.85 | KMT2A (0.49) | KMT2AMEN1CRHBPCRHR2POLB | |
| SCHEMBL24251268 | 0.85 | KMT2A (0.49) | KMT2AMEN1CRHBPCRHR2POLB | |
| SCHEMBL26418060 | 0.84 | KMT2A (0.55) | KMT2AMEN1CRHBPCRHR2POLB | |
| SCHEMBL24251263 | 0.84 | KMT2A (0.67) | KMT2AMEN1CRHBPCRHR2POLB | |
| SCHEMBL24614125 | 0.83 | KMT2A (0.58) | KMT2AMEN1CRHBPCRHR2POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11860390-B2 | Wavelength selective absorption filter, organic electroluminescent display device, and liquid crystal display device | FUJIFILM CORPORATION (JP) | 2024-01-02 | — | — | US | disclosed |
| US-11860390-B2 | Wavelength selective absorption filter, organic electroluminescent display device, and liquid crystal display device | FUJIFILM CORPORATION (JP) | 2024-01-02 | — | — | US | disclosed |
| US-20230384496-A1 | OPTICAL MEMBER FOR USE IN DISPLAY DEVICE AND DISPLAY DEVICE INCLUDING DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2023-11-30 | — | — | US | disclosed |
| US-20230384496-A1 | OPTICAL MEMBER FOR USE IN DISPLAY DEVICE AND DISPLAY DEVICE INCLUDING DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2023-11-30 | — | — | US | disclosed |
| US-20230288610-A1 | WAVELENGTH SELECTIVE ABSORPTION FILTER AND DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2023-09-14 | — | — | US | disclosed |
| US-20230125712-A1 | SELF-LUMINOUS DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2023-04-27 | — | — | US | disclosed |
| US-20230125712-A1 | SELF-LUMINOUS DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2023-04-27 | — | — | US | disclosed |
| US-20230026009-A1 | WAVELENGTH SELECTIVE ABSORPTION FILTER, POLARIZING PLATE, ORGANIC ELECTROLUMINESCENT DISPLAY DEVICE, AND LIQUID CRYSTAL DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2023-01-26 | — | — | US | disclosed |
| US-20230012898-A1 | LAMINATE, DISPLAY DEVICE, AND ORGANIC ELECTROLUMINESCENT DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2023-01-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230012898-A1 | LAMINATE, DISPLAY DEVICE, AND ORGANIC ELECTROLUMINESCENT DISPLAY DEVICE | EPCAM, ICAM1, STRA6 | KMT2A 1193/4885MEN1 4080/4885CRHBP 3014/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.